People · Operator
Named in public records as an officer, director or promoter · active 2009–2018 · Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Velomedix, Inc. | — | Biotechnology | Series A | $27.3M | $335.9M | 2009 |
| Murj, Inc. | — | Other Technology | Series A | $9.6M | $235.8M | 2018 |
Marc Galletti at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Marc Galletti on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jon Callaghan | 1 | 20 |
| Daniel Burnett | 1 | 11 |
| Andrew Cleeland | 1 | 5 |
| John Dean | 1 | 5 |
| J. Casey McGlynn | 1 | 5 |
| Ken Ludlum | 1 | 3 |
| Casey McGlynn | 1 | 3 |
| Jim Dennis | 1 | 2 |
| Jeff Gold | 1 | 2 |
| Reed Gaither | 1 | 2 |
| Mark Bartell | 1 | 1 |
| Todd Butka | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.